Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with IbrutinibJuan Carlo Avalon, Brijesh Patel, Lauren Veltri et al.|Cardio-Oncology|2021Cited by 19
Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma – a Phase II StudyCarl Shultz, Lauren Veltri, Chelby Wakefield et al.|Transplantation and Cellular Therapy|2021Cited by 0
Pre-Existing Cardiovascular Disease Increases Risk of Atrial Arrhythmia in Cancer Patients Treated with IbrutinibJuan Carlo Avalon, Brijesh Patel, Jacob Fuqua et al.|Research Square|2021Cited by 0
PRE-EXISTING CARDIOVASCULAR DISEASE INCREASES RISK OF ATRIAL ARRHYTHMIA IN CANCER PATIENTS TREATED WITH IBRUTINIBJuan Carlo Avalon, Brijesh Patel, Jacob Fuqua et al.|Journal of the American College of Cardiology|2021Cited by 0